You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 8, August 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Ophthalmic Molecular Genetics
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Glaucoma
 •Genetics
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Glaucoma Phenotype in Pedigrees With the Myocilin Thr377Met Mutation

David A. Mackey, MD, FRANZCO; Danielle L. Healey, BSc; John H. Fingert, MD, PhD; Michael A. Coote, FRANZCO; Tiffany L. Wong, BAppSci; Colleen H. Wilkinson, BAppSci; Paul J. McCartney, FRANZCO; Julian L. Rait, FRANZCO; A. Pauline de Graaf, MD; Edwin M. Stone, MD, PhD; Jamie E. Craig, FRANZCO, DPhil

Arch Ophthalmol. 2003;121:1172-1180.

Objective  To investigate the phenotype and age-related penetrance of primary open-angle glaucoma (POAG) in Australian families with the myocilin mutation Thr377Met.

Method and Design  Cross-sectional genetic study. Four unrelated pedigrees carrying the Thr377Met mutation were ascertained from more than 2000 consecutive cases of POAG in the Glaucoma Inheritance Study in Tasmania and from families with glaucoma referred to the study from throughout Australia. Index cases and available family members were examined for signs of glaucoma, and the presence of the GLC1A Thr377Met mutation was ascertained by single-strand conformation polymorphism analysis and subsequent direct sequencing.

Results  From the 4 pedigrees carrying the Thr377Met mutation, 23 individuals with either ocular hypertension (OHT) or POAG were found, with a mean ± SD age at diagnosis of 41.2 ± 11.5 years, and a mean peak intraocular pressure of 31.7 ± 9.9 mm Hg. A further 9 mutation carriers older than 18 years were studied who as yet showed no signs of OHT or POAG (6 of these 9 were younger than 30 years). A single individual with POAG was identified who did not carry the Thr377Met mutation. For Thr377Met carriers, age-related penetrance for OHT or POAG was 88% at age 30 years. A positive family history of POAG was present for 3 of the 4 index cases. Thirteen (57%) of the 23 Thr377Met carriers with OHT or POAG had undergone glaucoma drainage surgery. Although the glaucoma in these families appears to be pressure dependent, 2 individuals showed optic disc cupping before detected elevation in intraocular pressure. One family was of British origin, with a different background haplotype from the other 3 families from Greece or Macedonia, who shared a common haplotype.

Conclusions  The GLC1A Thr377Met mutation is associated with POAG that, in the pedigrees studied, had a younger age at onset and higher peak intraocular pressure than in pedigrees with the more common Gln368STOP mutation. In addition, patients with glaucoma with the Thr377Met mutation were more likely to have undergone glaucoma drainage surgery.


From the Centre for Eye Research Australia, University of Melbourne, Melbourne, Australia (Drs Mackey, Coote, Rait, and Craig and Mss Healey and Wilkinson); Menzies Centre for Population Health Research, University of Tasmania, Hobart, Australia (Drs Mackey, McCartney, and Craig and Mss Wong and Wilkinson); Department of Ophthalmology, The University of Iowa, Iowa City (Drs Fingert and Stone); Ocular Diagnostic Clinic, The Royal Victorian Eye & Ear Hospital, East Melbourne, Australia (Dr de Graff); and Department of Ophthalmology, Flinders University, Bedford Park, Australia (Dr Craig). The authors have no relevant financial interest in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Optic Nerve Head in Myocilin Glaucoma
Hewitt et al.
IOVS 2007;48:238-243.
ABSTRACT | FULL TEXT  

Myocilin Gly252Arg Mutation and Glaucoma of Intermediate Severity in Caucasian Individuals
Hewitt et al.
Arch Ophthalmol 2007;125:98-104.
ABSTRACT | FULL TEXT  

Screening for Glaucomatous Disc Changes Prior to Diagnosis of Glaucoma in Myocilin Pedigrees
Bennett et al.
Arch Ophthalmol 2007;125:112-116.
ABSTRACT | FULL TEXT  

The role of the Met98Lys optineurin variant in inherited optic nerve diseases
Craig et al.
Br J Ophthalmol 2006;90:1420-1424.
ABSTRACT | FULL TEXT  

A Large GLC1C Greek Family with a Myocilin T377M Mutation: Inheritance and Phenotypic Variability
Petersen et al.
IOVS 2006;47:620-625.
ABSTRACT | FULL TEXT  

Genetic dissection of myocilin glaucoma
Gong et al.
Hum Mol Genet 2004;13:R91-102.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.